@misc{indiciae76ff0362ae48,
  title = {The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas},
  author = {Cleverley, T. and Peddineni, S. and Guarner, J. and Cingolani, F. and Koehler, H. and Mocarski, E. S. and Kalman, D.},
  year = {2022},
  doi = {10.1101/2022.11.28.518230},
  url = {https://www.biorxiv.org/content/10.1101/2022.11.28.518230v1},
  note = {Source identifier: 10.1101/2022.11.28.518230}
}